Cue Biopharma, Inc. (CUE)
NASDAQ
Cue Biopharma, Inc. Net Income 2018–2025
Cue Biopharma, Inc. annual/quarterly net income history and growth rate from 2018 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Cue Biopharma, Inc. net income for the quarter ending March 31, 2026 was -5.2 M, a 57.75% decrease year-over-year.
- Cue Biopharma, Inc. net income for the twelve months ending March 31, 2026 was -33.4 M, a 20.90% decrease year-over-year.
- Cue Biopharma, Inc. annual net income for 2025 was -26.6 M, a 34.60% decrease from 2024.
- Cue Biopharma, Inc. annual net income for 2024 was -40.7 M, a 19.83% decrease from 2023.
- Cue Biopharma, Inc. annual net income for 2023 was -50.7 M, a 4.30% decrease from 2022.
- Cue Biopharma, Inc. annual net income for 2022 was -53.0 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cue Biopharma, Inc. Net Income — FAQ
Cue Biopharma, Inc. (CUE) net income over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Cue Biopharma, Inc.'s net income?
Cue Biopharma, Inc. (CUE) reported net income of -$27M for fiscal 2025.
Where can I see CUE's net income history?
The chart and table above show Cue Biopharma, Inc.'s net income by year and by quarter, including the growth rate.